Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors,mAbs

当前位置： X-MOL 学术 › mAbs › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors
mAbs ( IF 5.3 ) Pub Date : 2023-12-04 , DOI: 10.1080/19420862.2023.2287250
Sho Yoshimoto ₁ , Nicholas Chester ₂ , Ailian Xiong ₁ , Enrico Radaelli ₃ , Hong Wang ₂ , Marc Brillantes ₂ , Gayathri Gulendran ₄ , Patrick Glassman ₅ , Don L. Siegel _{4,

6} , Nicola J. Mason _{1,

3,

4}

Affiliation

PD-1 checkpoint inhibitors have revolutionized the treatment of patients with different cancer histologies including melanoma, renal cell carcinoma, and non-small cell lung carcinoma. However, only...

中文翻译：